Despite soaring global demand for healthcare, the challenge of profitably developing treatments has never been greater or more ethically complex. Can pharma giants strike the right balance?
Recent insights
16 Dezember 2024
Australian Government responds to review of the Modern Slavery Act
29 November 2024
Australian Privacy Reform Bill Tranche 1 passed Parliament: Key impacts for your business
23 Oktober 2024
OAIC's New AI Guidance: Navigating the Privacy Landscape for Australian Businesses
17 September 2024
Are you cyber ready? Australian businesses grapple with cyber resilience in 2024
17 September 2024
Cyber risk escalates: Are Australian businesses keeping up?
17 September 2024
On the minds of General Counsel
17 September 2024
Keeping watch: An evolving set of risk and regulatory changes on the horizon
13 September 2024
Australian Privacy Reform Bill Tranche 1: Key impacts for your business
12 September 2024
AI governance: Practical tips for directors to take into their next board meeting
9 September 2024
Australia releases new mandatory guardrails and voluntary standards on AI – what you need to know
1 September 2024
The Unified patent court and unitary patent – An introduction
1 September 2024
How to get a Unitary Patent
Key contacts
Alan Montgomery
Partner, Head of Pharmaceuticals Sector, Chair of India Group, London
Chris Parker KC
Partner, Head of Pharmaceuticals Sector, London
Natalie Bryce
Partner, Brisbane